Tumor Ablation Market 2019 | Global Industry Outlook by Medtronic, Boston Scientific, Abbott, Perseon Corporation, Philips, Mermaid Medical Group, SonaCare Medical, LLC, DFINE, Inc., Misonix, AngioDynamics, EDAP TMS

The Global Tumor Ablation Market report describe market introduction, product scope, market overview, market opportunities, market risk and market driving force. The Tumor Ablation Market report displays the competitive situation among top manufactures with sales, revenue and market share. the main perspective of the Global Tumor Ablation Market is to show global market by regions, sales, revenue and price of the market. It analyses the market by countries, by type, by application and by manufactures with sales, revenue and market share by key countries in these regions.

Global Tumor Ablation Market is expected to reach USD 3,495.0 million by 2024 from USD 1,669.7 million in 2016, at a CAGR of 9.8% in the forecast period 2017 to 2024.

Download exclusive PDF sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market

Global Tumor Ablation market By Type (Tumor Ablation Systems {Radio Frequency Ablation System, Microwave Ablation System, Cryoablation, High Intensity Focused Ultrasound , Laser Ablation System}, Image Guidance Products, Accessories), By Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer, Others), By Mode of Treatment (Surgical, Laparoscopic, Percutaneous), By End User (Hospitals, Oncology Clinics, Others), By Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) - Forecast to 2024

Company Analysis:

Medtronic, Boston Scientific Corporation, Abbott, Galil Medical Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, BVM Medical Limited, AngioDynamics, COMSOL Inc, EDAP TMS, and HealthTronics, Inc.

Key Drivers of Global Tumor Ablation Market:

Some of the major factors driving the market for global tumor ablation market are increasing incidences of cancer patients, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices. These factors increase the demand for devices such as tumor ablation systems and image guidance products.

• High treatment cost and side effects associated with ablation treatment may hinder the growth of this market.

• According to American Cancer Society, in 2017, approximately 1,688,780 new cancer cases were diagnosed and 600,920 cancer deaths were reported in the US.

• Many companies are increasingly focusing on technological advancement of devices in order to strengthen their product portfolios in the tumor ablation market.

Key Reasons to Purchase:

• To gain insightful analyses of the market and have comprehensive understanding of the Global Tumor Ablation Market and its commercial landscape.

• Assess the Tumor Ablation production processes, major issues, and solutions to mitigate the development risk.

• To understand the most affecting driving and restraining forces in the Tumor Ablation Market and its impact in the Global market.

• Learn about the market strategies that are being adopted by leading respective organizations.

• To understand the future outlook and prospects for Global Tumor Ablation Market.

Inquire more or share questions if any before the purchase on this report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tumour-ablation-market

Market Segmentation:

On the basis of type:

• Tumor Ablation Systems
• Image Guidance Products
• Accessories

On the basis of cancer type:

• Liver Cancer
• Brain Cancer
• Lung Cancer
• Bone Cancer
• Kidney Cancer
• Pancreatic Cancer
• Breast Cancer
• Others

Based on mode of treatment:

• Surgical
• Laproscopic
• Percutaneous

On the basis of end users:

• Hospital
• Oncology Clinics
• Others

Based on geography:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Table of Contents:

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. MARKET SCOPE
1.4. OVERVIEW OF GLOBAL TUMOR ABLATION MARKET
1.5. CURRENCY AND PRICING
1.6. LIMITATION
1.7. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCE
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. INCREASING PREVALENCE OF CANCER PATIENTS
3.1.2. TECHNOLOGICAL ADVANCEMENTS IN ABLATION DEVICES
3.1.3. RISING NUMBER OF HOSPITALS, SURGICAL, AND ABLATION CENTERS

3.2. RESTRAINTS

3.2.1. HIGH COST OF TUMOR ABLATION TREATMENT
3.2.2. SIDE EFFECTS ASSOCIATED WITH ABLATION TREATMENT
3.2.3. SHORTAGE OF SKILLED AND TRAINED PROFESSIONALS

3.3. OPPORTUNITIES

3.3.1. GROWTH POTENTIAL OFFERED BY DEVELOPING MARKETS
3.3.2. GROWING AWARENESS ABOUT ABLATION PROCEDURES

3.4. CHALLENGES

3.4.1. STRINGENT REGULATORY GUIDELINES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL TUMOR ABLATION MARKET, BY TYPE

6.1. OVERVIEW

6.2. TUMOR ABLATION SYSTEMS

6.2.1. RADIOFREQUENCY ABLATION SYSTEM (RFA)
6.2.2. MICROWAVE ABLATION SYSTEM
6.2.3. HIGH FREQUENCY FOCUSED ULTRASOUND ABLATION SYSTEM (HIFU)
6.2.4. LASER ABLATION SYSTEM
6.2.5. CRYOABLATION

6.3. IMAGE GUIDANCE PRODUCTS

6.4. ACCESSORIES

7. GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE

7.1. OVERVIEW
7.2. LIVER CANCER
7.3. BRAIN CANCER
7.4. LUNG CANCER
7.5. BONE CANCER
7.6. KIDNEY CANCER
7.7. PANCREATIC CANCER
7.8. BREAST CANCER
7.9. OTHERS

8. GLOBAL TUMOR ABLATION MARKET, BY MODE OF TREATMENT

8.1. OVERVIEW
8.2. SURGICAL
8.3. LAPAROSCOPIC
8.4. PERCUTANEOUS

9. GLOBAL TUMOR ABLATION MARKET, BY END USER

9.1. OVERVIEW
9.2. HOSPITALS
9.3. ONCOLOGY CLINICS
9.4. OTHERS

10. GLOBAL TUMOR ABLATION MARKET, BY GEOGRAPHY

10.1. OVERVIEW
10.2. NORTH AMERICA
10.3. EUROPE
10.4. ASIA-PACIFIC
10.5. SOUTH AMERICA
10.6. MIDDLE EAST AND AFRICA

11. GLOBAL TUMOR ABLATION MARKET, COMPANY LANDSCAPE

11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12. COMPANY PROFILES

1.1. MEDTRONIC

1.2. STRYKER

1.3. TERUMO CORPORATION

1.4. INTEGRA LIFESCIENCES CORPORATION

1.5. KONINKLIJKE PHILIPS N.V.

1.6. NEUWAVE MEDICAL, INC (ACQUIRED BY ETHICON US, LLC, SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)

1.7. BOSTON SCIENTIFIC CORPORATION

1.8. MERMAID MEDICAL A/S

1.9. SONACARE MEDICAL, LLC

1.10. MERIT MEDICAL SYSTEMS, INC

1.11. BVM MEDICAL LIMITED

1.12. INSIGHTEC LTD

1.13. ABBOTT

1.14. VYTRONUS, INC

1.15. BALYIS MEDICAL

1.16. EDAP TMS

1.17. ATRICURE, INC.

1.18. FCARE SYSTEMS

1.19. ECO, INC.

1.20. NONINVASIVE MEDICAL DEVICES, LTD.

Access Full Report @ https://databridgemarketresearch.com/toc/?dbmr=global-tumour-ablation-market

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.